COMPANY DESCRIPTION Mirai Bio is a privately-held, Flagship-founded biotechnology company that is delivering genetic medicines from promise to performance. Mirai was built to solve one of the field’s central challenges: achieving precise, scalable delivery of diverse
BandLevel 5 Job Description SummaryLocation: Cambridge LI#Onsite The Oncology Pathology and Biomarkers group within Oncology Translational Research at Novartis Biomedical Research is seeking an accomplished Imaging Scientist to join the Image Analysis team in Cambridge. This
Employment Status:Full time Shift:Day/Evening/Night (United States of America) Facility:1906 Belleview Ave SE - Roanoke Requisition Number:R147887 Intermediate Care Tech - Military Medic and Corpsmen Program - FT (Open) How You’ll Help Transform Healthcare:Intermediate Care Tech -
Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department.
When you join the growing BILH team, youre not just taking a job, you’re making a difference in people’s lives.Under the general supervisor of the Anatomic Pathology Manager, or designee, the Pathology Technician performs all specific
Company Summary: Serif Biomedicines is a privately held, early-stage biotechnology company developing a novel approach to gene therapy that can address currently untreatable diseases. It was founded by Flagship Pioneering, an innovation enterprise that conceives, creates,
What if…you could join an organization that creates, resources, and builds life sciences companies that invent breakthrough technologies to transform health care? COMPANY DESCRIPTION In today’s healthcare system, disease diagnosis often relies on invasive procedures, such
Company Summary: Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated
Company Summary: Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated
Company Overview: Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is leveraging its proprietary Prime Editing platform, a versatile, precise and